Blueshift Asset Management LLC acquired a new stake in Camtek Ltd. (NASDAQ:CAMT – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 7,819 shares of the semiconductor company’s stock, valued at approximately $624,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Blue Trust Inc. lifted its stake in Camtek by 4.1% in the second quarter. Blue Trust Inc. now owns 2,721 shares of the semiconductor company’s stock valued at $341,000 after buying an additional 108 shares during the period. Petra Financial Advisors Inc. lifted its position in shares of Camtek by 1.5% during the 2nd quarter. Petra Financial Advisors Inc. now owns 8,290 shares of the semiconductor company’s stock valued at $1,038,000 after acquiring an additional 120 shares during the period. Advisors Asset Management Inc. boosted its stake in Camtek by 78.8% during the third quarter. Advisors Asset Management Inc. now owns 329 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 145 shares in the last quarter. Van ECK Associates Corp grew its holdings in Camtek by 1.6% in the third quarter. Van ECK Associates Corp now owns 9,561 shares of the semiconductor company’s stock worth $755,000 after purchasing an additional 148 shares during the period. Finally, Ellsworth Advisors LLC grew its holdings in Camtek by 3.4% in the second quarter. Ellsworth Advisors LLC now owns 7,393 shares of the semiconductor company’s stock worth $926,000 after purchasing an additional 245 shares during the period. Institutional investors own 41.93% of the company’s stock.
Camtek Stock Up 1.1 %
Shares of NASDAQ:CAMT opened at $71.89 on Thursday. The business’s 50 day moving average is $78.73 and its 200 day moving average is $95.12. Camtek Ltd. has a 12-month low of $59.33 and a 12-month high of $140.50. The stock has a market cap of $3.26 billion, a price-to-earnings ratio of 32.77, a PEG ratio of 1.30 and a beta of 1.38. The company has a quick ratio of 4.36, a current ratio of 5.28 and a debt-to-equity ratio of 0.38.
Analyst Ratings Changes
CAMT has been the topic of a number of research analyst reports. Northland Securities increased their price objective on shares of Camtek from $99.00 to $102.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Northland Capmk upgraded Camtek from a “hold” rating to a “strong-buy” rating in a report on Monday, August 5th. Needham & Company LLC restated a “buy” rating and set a $95.00 price objective on shares of Camtek in a report on Wednesday, November 13th. StockNews.com raised Camtek from a “sell” rating to a “hold” rating in a research report on Wednesday, November 20th. Finally, B. Riley reduced their price target on shares of Camtek from $150.00 to $140.00 and set a “buy” rating for the company in a research report on Friday, August 2nd. One investment analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $110.57.
Get Our Latest Stock Analysis on CAMT
About Camtek
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.
Further Reading
- Five stocks we like better than Camtek
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Consumer Staples Stocks, Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Using the MarketBeat Stock Split Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding CAMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Camtek Ltd. (NASDAQ:CAMT – Free Report).
Receive News & Ratings for Camtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camtek and related companies with MarketBeat.com's FREE daily email newsletter.